JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.

Credit available for this activity expires: 12/10/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/jak-inhibitors-rheumatoid-arthritis-overcoming-challenges-2025a1000yav?ecd=bdc_podcast_libsyn_mscpedu